Celularity Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+32.0% +$1M
$-3M
Free Cash Flow↑+32.6% +$1M
$-3M
Investing Cash Flow
$0
Financing Cash Flow↑+1644.9% +$11M
$11M
Capex
$56K
Stock Buybacks
—
Stock-Based Comp
$471K
D&A↓-3.9% -$73K
$2M
SBC Allocated Expense↑+19.6% +$575K
$4M